Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
Vidaza
Can This Celgene Drug Defy the Patent Cliff?
Can This Celgene Drug Defy the Patent Cliff?
Motley Fool
Celgene
myelodysplastic syndrome
patents
Vidaza
Revlimid Ramp-Up, New Drug Launches Make Celgene a Buy
Revlimid Ramp-Up, New Drug Launches Make Celgene a Buy
Motley Fool
Abraxane
apremilast
Celgene
pomalidomide
Revlimid
Vidaza
News
Celgene Corporation: Take the Money and Run
Seeking Alpha
Celgene
pipelines
Revlimid
Vidaza
»
Login
or
register
to post comments
News
Celgene's Healthy Outlook
Yahoo/Zacks.com
Celgene
Pharmion
Revlimid
Thalomid
Vidaza
»
Login
or
register
to post comments
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT